title: p53 Protects renal inner medullary cells from hypertonic stress by restricting DNA replication.
abstract: We previously found that p53 upregulation by hypertonicity protected renal inner medullary collecting duct (mIMCD3) cells from apoptosis. The purpose of the present study was to investigate the mechanism by which p53 protects the cells. We now find that hypertonicity (NaCl added to a total of 500 mosmol) inhibits DNA replication and delays G(1)-S transition as concluded from analysis of cell cycle distributions and bromodeoxyuridine (BrDU) incorporation rates. Lowering of p53 with p53 antisense oligonucleotide attenuated such effects of hypertonicity, resulting in an increased number of apoptotic cells in S phase and cells with >4 N DNA. Results with synchronized cells are similar, showing that cells in the early S phase are more sensitive to hypertonicity. Immunocytochemistry revealed that p53 becomes phosphorylated on Ser(15) and translocates to the nucleus in S both in isotonic and hypertonic conditions. Caffeine (2 mM) greatly reduces the p53 level and Ser(15) phosphorylation, followed by a remarkable increase of DNA replication rate, by failure of hypertonicity to inhibit it, and by reduction of cell number during hypertonicity. Finally, inhibition of DNA replication by the DNA polymerase inhibitor aphidicolin significantly improves cell survival, confirming that keeping cells in G(1) and decreasing the rate of DNA replication is protective and that these actions of p53 most likely are what normally help protect cells against hypertonicity.
authors.affiliation: National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg. 10, Rm. 6N260, Bethesda, MD 20892-1603, USA. dmitrien@nhlbi.nih.gov
authors.forename: N
authors.initials: N
authors.lastname: Dmitrieva
authors.forename: L
authors.initials: L
authors.lastname: Michea
authors.forename: M
authors.initials: M
authors.lastname: Burg
mesh_terms: D000818:Animals; D016590:Aphidicolin / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D004261:DNA Replication / Q000187:drug effects / Q000502:physiology*; D016193:G1 Phase; D016195:G2 Phase; D016158:Genes, p53; D007679:Kidney Medulla / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D007685:Kidney Tubules, Collecting / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology; D016196:S Phase; D012462:Saline Solution, Hypertonic / Q000494:pharmacology*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: D020319:Oligodeoxyribonucleotides, Antisense; D012462:Saline Solution, Hypertonic; D016159:Tumor Suppressor Protein p53; D016590:Aphidicolin